5 results about "Scientific study" patented technology

The application of unilateral or bilateral permanent prostheses to the labium majus in the external genitalia of women for reconstructive and aesthetic purposes may make it appear fuller. The labium majus may lose its fullness and symmetry due to menopause, rapid weight gain and loss, traumas, cancers, and infectious diseases. Aesthetic interventions (e.g., hyaluronic acid filler injection and fat grafting) aiming to provide the labium majus with fullness have become very popular in recent years. The hyaluronic acid filler is used for reconstructive purposes to achieve fullness in labium majus. However, the maximum amount that can be injected is 3 mL, which is often insufficient for the desired outcome and its effect lasts for a maximum of 1 year. Autologous fat grafting is administered by taking 18–120 mL of fat from patients themselves; however, its effect usually lasts 1 to 4 years. The application of a prosthesis will provide labium majus with fullness and this effect will be long-lasting. The outer edge of the prosthesis is convex and the inner edge is concave. In male genitalia, prostheses have been used since 1950 to provide the testicles with fullness. Scientific studies have shown that these prostheses positively affect self-confidence and body perception indices in men.

1. Name of the product in this design: Animal Ventilator. 2. Intended use of this design: for scientific research experiments in clinical medicine and veterinary medicine, respiratory therapy and emergency care for animals, etc. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design's key points: 3D view 1.

Oncology faces a digital chasm in its quest for personalized treatments. Despite the adoption of electronic health records (EHR), most hospitals are ill-equipped for data science research. Embodiments herein describe a continuously learning infrastructure through which multimodal health data are systematically organized and data quality is assessed with the goal of applying artificial intelligence to address unmet clinical needs. Embodiments describe systems and methods for improved cancer prognostics, including by obtaining electronic medical records and performing natural language processing thereon. Additional embodiments apply term frequency inverse document frequency to identify terms that are predictive for cancer survival. Additional embodiments are capable of performing in silico clinical trials based on information comprised in a collection of health records.

The technical scheme of the invention discloses an orthopedics-related drug patent value evaluation system, which is characterized by comprising an orthopedics-related drug evaluation reference standard data acquisition module; an orthopedic related drug patent data integration module; a multi-source data feature construction module; an orthopedic related drug patent comprehensive value evaluation model; and an evaluation and result output module. According to the system disclosed by the invention, traditional patent evaluation indexes such as law, economy and technology can be combined with clinical effects, scientific research, medicine and health policies, supervision systems and the like of orthopedic drugs, so that dynamic evaluation and prospective prediction of the patent values of the orthopedic related drugs are realized. Meanwhile, multi-source data acquisition and an advanced machine learning algorithm are introduced, data scientificity and rationality are improved by using multiple model methods, an evaluation system exclusive to the orthopedics-related pharmaceutical industry is constructed, a closed-loop process of achievement transformation-patent value evaluation is formed, and scientificity, adaptability and practicability of evaluation results are ensured.

This invention discloses the application of ergothioneine as a biomarker in the preparation of diagnostic products for rheumatoid arthritis (RA), belonging to the biomedical field. This invention uses high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS / MS) to detect the content of ergothioneine in samples, thereby achieving the diagnosis of RA in patients. Analysis showed that the area under the curve (AUC) of ergothioneine in distinguishing between the RA and OA groups was 0.7880, while the AUC in distinguishing between the RA and HC groups was 0.8804, indicating its good diagnostic value. This invention provides a novel biomarker for RA, offering a basis for further examination by clinicians, and has significant scientific research and clinical application value, providing a practical means for diagnosing RA.